Trial Profile
Paracetamol And Ibuprofen/Indomethacin in Closing Patent Ductus Arteriosus of Preterm Infants - Randomised, Placebo-controlled Multicentre Trial
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2023
Price :
$35
*
At a glance
- Drugs Ibuprofen lysinate (Primary) ; Indometacin (Primary) ; Paracetamol (Primary)
- Indications Patent ductus arteriosus
- Focus Therapeutic Use
- Acronyms PAI
- 01 Nov 2022 Planned End Date changed from 1 Mar 2023 to 1 Mar 2024.
- 01 Nov 2022 Planned primary completion date changed from 1 Sep 2022 to 1 Jan 2024.
- 15 Jun 2019 Planned number of patients changed from 20 to 60.